Dalle miniere polacche alla Haloterapia Moderna.
“Halos - Als” in greco vuol dire sale. L’”halotherapy” (haloterapia) è un trattamento terapeutico per i benefici derivanti per l'assunzione aerea (respirazione) di Sale Puro Micronizzato (cloruro di sodio) cioè di sale medicale di roccia purissima.
Il trattamento è basato su un rimedio naturale conosciuto da secoli per i suoi benefici effetti sulle malattie del sistema respiratorio. Non è un sostitutivo della terapia antibiotica o cortisonica ma frequentemente permette di ridurne in modo consistente l’assunzione migliorando la qualità della vita del paziente.
I monaci nel medioevo portavano i malati nelle grotte di sale e lasciavano che respirassero particelle di sale generate dalla rottura delle stalattiti. Nel XIX secolo questo trattamento ebbe un picco di popolarità osservando che i minatori delle grotte di sale in Polonia presentavano una drastica riduzione, rispetto alla popolazione in generale, delle patologie polmonari.
I primi studi scientifici sul microclima delle Stanza di Sale risalgono al fisico polacco F. Bochkowsky nel 1843 dove si determinano le importanti caratteristiche di grandezza e leggerezza delle molecole di sale che determinano i risultati per la salute (Haloterapia di Qualità). Dalle sue prime valutazioni, l’haloterapia ha avuto una diffusione sempre più consistente sino ad accreditarsi come terapia medica ufficialmente riconosciuta in numerosi paesi dell’est Europa. Ulteriori sperimentazioni sono in corso per accreditarsi nell’ambito di tutti i paesi della CEE.
Il trattamento nella Grotta di Sale è scandito da dettami scientifici ben definiti. E' importante avere la certezza che il generatore sia in grado di "sminuzzare" alla grandezza inspirabile e che il trattamento dell'aria sia gestito con accortezza.
World References:
|
|
| |
|
[Halotherapy--a new treatment of bacterial vaginosis] | ||
|
|
| |
|
[Clinical significance of cytological characteristics of bronchial inflammation in obstructive pulmonary diseases] | ||
|
|
| |
|
[Halotherapy in combined non-puncture therapy of patients with acute purulent maxillary sinusitis] | ||
|
| ||
|
[Efficacy of therapeutic use of ultrasound and sinusoidal modulated currents combed with halotherapy in patient with occupational toxic-dust bronchitis] | ||
|
|
| |
|
[Effects of halotherapy on free radical oxidation in patients with chronic bronchitis] | ||
|
|
| |
|
[Effectiveness of halotherapy of chronic bronchitis patients] | ||
|
|
| |
|
[The scientific validation and outlook for the practical use of halo-aerosol therapy] | ||
|
|
| |
|
[Halotherapy in the combined treatment of chronic bronchitis patients] | ||
|
|
| |
|
[The use of an artificial microclimate chamber in the treatment of patients with chronic obstructive lung diseases] | ||
|
|
| |
|
Halotherapy for treatment of respiratory diseases. | ||
|
|
| |
|
[Bronchial hyperreactivity to the inhalation of hypo- and hyperosmolar aerosols and its correction by halotherapy] | ||
|
|
| |
|
[The use of halotherapy for the rehabilitation of patients with acute bronchitis and a protracted and recurrent course] | ||
Ter Arkh. 2004;76(3):36-9. Links
[Clinical significance of cytological characteristics of bronchial inflammation in obstructive pulmonary diseases]
[Article in Russian]
AIM: To evaluate a clinical role of cytological characteristics of induced sputum (IS) and bronchial lavage (BL) in patients with different forms of bronchial asthma (BA) or chronic obstructive bronchitis (COB). MATERIAL AND METHODS: The study included 128 BA patients (53 males and 75 females) at the age of 17 to 70 years (mean age 51.3 +/- 8.4 years) and 53 COB patients (32 males and 21 females) at the age 17 to 70 years. The material for the cytological examination was BL obtained by fibrobronchoscopy and IS obtained after 20-min halotherapy. RESULTS: Percentages of eosinophils, neutrophils, lymphocytes and alveolar macrophages in IS and BL have the same trends and a highly significant correlation coefficient by all the studied cells both in BA and COB patients. CONCLUSION: It was found possible to use IS cytology for evaluation of air way inflammation in BA and COB patients.
PMID: 15108456 [PubMed - indexed for MEDLINE]
Vestn Otorinolaringol. 2003;(4):42-4. Links
[Halotherapy in combined non-puncture therapy of patients with acute purulent maxillary sinusitis]
[Article in Russian]
Halotherapy was applied for non-puncture treatment of 45 patients with acute purulent maxillary sinusitis. The response was evaluated by changes in clinico-immunological, cytological, x-ray and bacteriological parameters. Halotherapy was found effective in the treatment of acute purulent maxillary sinusitis without puncture.
PMID: 13677023 [PubMed - indexed for MEDLINE]
Klin Med (Mosk). 2000;78(12):37-40. Links
[Effects of halotherapy on free radical oxidation in patients with chronic bronchitis]
[Article in Russian]
Registration of luminol-dependent chemoluminescence of blood cells and iron-induced chemoluminescence of the serum was used to study generation of active oxygen forms and lipid peroxidation in patients with chronic bronchitis (CB). 49 patients with lingering CB showed inhibition of blood cell function and enhancement of lipid peroxidation. The addition of halotherapy to combined treatment of these patients promoted correction of the disorders and improvement of CB course.
PMID: 11210350 [PubMed - indexed for MEDLINE]
Vopr Kurortol Fizioter Lech Fiz Kult. 2000 Nov-Dec;(6):21-4. Links
[Effectiveness of halotherapy of chronic bronchitis patients]
[Article in Russian]
The chemoluminescence test in 49 patients with lingering inflammatory chronic bronchitis has revealed inhibition of generation of active oxygen forms in the whole blood, intensification of lipid peroxidation in the serum, depression of local immunity. Administration of halotherapy to the above patients results in correction of disturbances of free-radical oxidation, improves local immunity and clinical course of the disease.
PMID: 11197648 [PubMed - indexed for MEDLINE]
Vopr Kurortol Fizioter Lech Fiz Kult. 2000 Jan-Feb;(1):21-4. Links
[The scientific validation and outlook for the practical use of halo-aerosol therapy]
[Article in Russian]
The paper describes a new medical technique--halo-aerosol therapy, the main acting factor of which is dry highly dispersed aerosol of sodium chloride in natural concentration. Halo-aerosol therapy represents a new trend in aerosol medicine. It includes two methods: halotherapy and halo-inhalation. Biophysical and pathophysiological foundations of the new method, how it can be realized are outlined. Clinical reasons are provided for application of halo-aerosol therapy for prevention, treatment and rehabilitation of patients with respiratory diseases. Characteristics and differences of the two halo-aerosol therapy variants are analysed.
PMID: 11094875 [PubMed - indexed for MEDLINE]
Voen Med Zh. 1999 Jun;320(6):34-7, 96. Links
[Halotherapy in the combined treatment of chronic bronchitis patients]
[Article in Russian]
Halotherapy proved to be a highly effective method in a complex sanatorium treatment of patients with chronic bronchitis. Its use promotes more rapid liquidation of clinical manifestations of disease, improves indices of vent function of lungs, especially those values that characterize bronchial conduction (volume of forced exhalations per second, index Tiffno), increases tolerance to physical load, normalizes indices of reduced immunity and leads to increasing the effectiveness of patient treatment in sanatorium.
PMID: 10439712 [PubMed - indexed for MEDLINE]
Vopr Kurortol Fizioter Lech Fiz Kult. 1997 Jul-Aug;(4):19-21. Links
[The use of an artificial microclimate chamber in the treatment of patients with chronic obstructive lung diseases]
[Article in Russian]
Halotherapy was used for sanatorium rehabilitation in 29 patients with chronic obstructive pulmonary diseases (chronic bronchitis and asthma). Significant positive effects of this method resulted in the improvement of the flow-volume parameters curve of lung function and in hypotensive effects on blood pressure. Halotherapy is recommended for use in patients suffering from chronic obstructive pulmonary diseases with hypertension or coronary heart disease.
PMID: 9424823 [PubMed - indexed for MEDLINE]
J Aerosol Med. 1995 Fall;8(3):221-32. Links
Halotherapy for treatment of respiratory diseases.
Saint-Petersburg Pavlov National Medical University, Russia.
This work elucidates the questions upon the development of a new drug-free method of a respiratory diseases treatment. Halotherapy (HT)--is mode of treatment in a controlled air medium which simulates a natural salt cave microclimate. The main curative factor is dry sodium chloride aerosol with particles of 2 to 5 mkm in size. Particles density (0.5-9 mg/m3) varies with the type of the disease. Other factors are comfortable temperature- humidity regime, the hypobacterial and allergen-free air environment saturated with aeroions. The effect of HT was evaluated in 124 patients (pts) with various types of respiratory diseases. The control group of 15 pts received placebo. HT course consisted of 10-20 daily procedures of 1 hour. HT resulted in improvements of clinical state in the most of patients. The positive dynamics of flow-volume loop parameters and decrease of bronchial resistance measured by bodyplethysmography were observed. The changes in control group parameters after HT were not statistically significant. The specificity of this method is the low concentration and gradual administration of dry sodium chloride aerosol. Data on healing mechanisms of a specific airdispersive environment of sodium chloride while while treatment the respiratory diseases are discussed.
PMID: 10161255 [PubMed - indexed for MEDLINE]
Ter Arkh. 1996;68(8):24-8. Links
[Bronchial hyperreactivity to the inhalation of hypo- and hyperosmolar aerosols and its correction by halotherapy]
[Article in Russian]
18 bronchial asthma (BA) patients (12 with mild and 6 with moderate disease) were examined before and after halotherapy (HT) for airways reactivity using provocative tests with ultrasonic inhalations of purified water (UIPW) and hypertonic salt solution (HSS). Bronchial hyperreactivity (BHR) to UIPW and HSS before treatment occurred in 13 and 11 patients (72 and 69%, respectively). HT reduced BHR in 2/3 and 1/2 of the patients, respectively. In the rest patients BHR was unchanged or increased, being so to UIPW only in patients with atopic asthma in attenuating exacerbation. Clinical efficacy of HT and initial BHR to UIPW correlated (r = 0.56; p < 0.05). No correlation was found between HT efficacy and initial BHR to HSS.
PMID: 9019826 [PubMed - indexed for MEDLINE]
Vopr Kurortol Fizioter Lech Fiz Kult. 1995 Jan-Feb;(1):11-5. Links
[The use of halotherapy for the rehabilitation of patients with acute bronchitis and a protracted and recurrent course]
[Article in Russian]
- Borisenko LV,
- Chervinskaia AV,
- Stepanova NG,
- Luk'ian VS,
- Goncharova VA,
- Pokhodzei IV,
- Krivitskaia VZ,
- Vishniakova LA,
- Pokhaznikova MA,
- Faustova ME, et al.
Halotherapy was used for rehabilitation in 25 patients with acute bronchitis of long-standing and recurrent types. The main therapeutic action was ensured by aerodispersed medium saturated with dry highly dispersed sodium chloride aerosol, the required mass concentration being maintained in the range of 1 to 5 mg/m3. Therapy efficacy was controlled through assessment of clinical, functional, immunological and microbiological findings. Metabolic activity values were taken into consideration as well. Positive dynamics of the function indices in the clinical picture resulted from elimination of pathogenic agents, control of slowly running inflammatory lesions and stimulation of some immune system factors. Favourable changes in metabolic activity were present: normalization of serotonin excretion, marked decrease of unbalance in lipid peroxidation-antioxidant system.
PMID: 7785211 [PubMed - indexed for MEDLINE]